InsidersTradesSigma
Track the 엔솔바이오사이언스 share price and the full management transaction log of the company, a listed issuer based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 엔솔바이오사이언스 has published 7 insider filings. Market capitalisation: €158.9bn. The latest transaction was disclosed on 13 July 2026 (Purchase). Among the most active insiders: 형인우. The full history is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
7 of 7 declarations
Ensol Bioscience is a company specializing in the health and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative biopharmaceutical solutions.